Patent_application_number,Applicant_name,Year_of_application,Patent_system
US7157250B2,AJINOMOTO,2007,USPTO
US7157439B2,UNIVERSITY OF CALIFORNIA,2007,USPTO
US7162371B1,UNIV GEORGIA,2007,USPTO
US7167802B2,"WYETH; MADISON, NJ; US;",2007,USPTO
US7169580B1,ROCHE DIAGNOSTICS,2007,USPTO
US7169751B2,BAYER,2007,USPTO
US7175658B1,MULTI-GENE VASCULAR SYSTEMS LTD.; HAIFA; IL;,2007,USPTO
US7179890B2,THE JOHNSON & JOHNSON,2007,USPTO
US7183075B2,VANDERBILT UNIVERSITY,2007,USPTO
US7186407B2,NOVARTIS,2007,USPTO
US7186539B1,DAHALER CORPORATION,2007,USPTO
US7189546B2,ONO PHARMACEUTICAL CO,2007,USPTO
US7189551B2,"BIOPTIK TECHNOLOGY, INC.; TAIPEI; TW;",2007,USPTO
US7193069B2,RESEARCH ASSOCIATION FOR BIOTECHNOLOGY; TOKYO; JP;,2007,USPTO
US7198930B2,TAKEDA CHEMICAL INDUSTRIES LTD,2007,USPTO
US7205110B2,BRISTOL-MYERS SQUIBB COMPANY,2007,USPTO
US7205135B2,BAYER,2007,USPTO
US7208282B2,MERCK,2007,USPTO
US7208581B1,SANFORD BURHAM PREBYS,2007,USPTO
US7211418B2,DSM IP ASSETS BV,2007,USPTO
US7223406B2,UNIVERSITY OF CALIFORNIA,2007,USPTO
US7223557B2,BRISTOL-MYERS SQUIBB COMPANY,2007,USPTO
US7226748B2,"AURELIUM BIOPHARMA, INC.; MONTREAL, QUEBEC; CA;",2007,USPTO
US7226755B1,THE PROCTER & GAMBLE,2007,USPTO
US7227006B2,SANOFI,2007,USPTO
US7229755B1,DANA FARBER CANCER INSTITUTE,2007,USPTO
US7229774B2,UNIVERSITY OF MICHIGAN,2007,USPTO
US7235236B2,UNIVERSITY OF CALIFORNIA,2007,USPTO
US7235363B2,PFIZER,2007,USPTO
US7238213B2,"BECTON, DICKINSON AND COMPANY",2007,USPTO
US7244877B2,BAYER,2007,USPTO
US7256010B2,TAKEDA CHEMICAL INDUSTRIES LTD,2007,USPTO
US7258860B2,GSK PLC,2007,USPTO
US7258988B2,TAKEDA CHEMICAL INDUSTRIES LTD,2007,USPTO
US7259015B2,OXFORD BIOMEDICA,2007,USPTO
US7262062B2,KEIO UNIVERSITY,2007,USPTO
US7262280B1,TAKEDA CHEMICAL INDUSTRIES LTD,2007,USPTO
US7264926B2,TAKEDA CHEMICAL INDUSTRIES LTD,2007,USPTO
US7264946B2,"OCUGEN, INC",2007,USPTO
US7273616B2,COLUMBIA UNIVERSITY,2007,USPTO
US7279284B2,ROCHE DIAGNOSTICS,2007,USPTO
US7279314B2,MARINE BIOTECHNOLOGY INST,2007,USPTO
US7282357B2,BASF,2007,USPTO
US7288385B2,THE SALK INSTITUTE FOR BIOLOGICAL STUDIES,2007,USPTO
US7288406B2,"OCUGEN, INC",2007,USPTO
US7291767B2,DOW,2007,USPTO
US7294459B1,HARVARD MEDICAL SCHOOL,2007,USPTO
US7294475B2,TAKEDA CHEMICAL INDUSTRIES LTD,2007,USPTO
US7297523B2,"XENON PHARMACEUTICALS INC.; VANCOUVER, BRITISH COLOMBIA; CA;",2007,USPTO
US7301016B2,TAKEDA CHEMICAL INDUSTRIES LTD,2007,USPTO
US7303892B1,TAKEDA CHEMICAL INDUSTRIES LTD,2007,USPTO
US7306923B2,GALAPAGOS,2007,USPTO
US7309594B1,TAKEDA CHEMICAL INDUSTRIES LTD,2007,USPTO
US7309604B2,"LICENTIA, LTD. AND LUDWIG INSTITUTE FOR CANCER RESEARCH; HELSINKI; FI;",2007,USPTO
US7309772B2,"ICAGEN, INC",2007,USPTO
US7309815B2,CORTEVA,2007,USPTO